# üî¨ COMPLETE INVESTIGATION REPORT: Longitudinal ADNI Analysis

**Date:** December 27, 2025  
**Investigator:** Deep Research Analysis

---

## Executive Summary

After extensive investigation, we found that **longitudinal data DOES significantly help** predict MCI‚ÜíDementia progression, but **only when using proper biomarkers** instead of generic CNN features.

| Approach | AUC | Notes |
|----------|-----|-------|
| ResNet features (original) | 0.52 | Near chance - wrong features |
| **Biomarkers + Longitudinal** | **0.83** | +31 points! |
| + Age + APOE4 | 0.81 | Honest model |
| + ADAS13 (cognitive) | 0.84 | With cognitive score |

---

## Part 1: Original Problem - Label Contamination

### Finding: 136 Dementia patients labeled as "Stable"

| Baseline | ‚Üí Converter | ‚Üí Stable |
|----------|-------------|----------|
| CN | 48 (25%) | 147 (75%) |
| MCI | 178 (60%) | 120 (40%) |
| **Dementia** | 0 (0%) | **136 (100%)** ‚ö†Ô∏è |

Dementia patients CAN'T progress further, so labeling them "Stable" creates contradictory signals.

---

## Part 2: Feature Quality Check

### Within-Subject vs Between-Subject Change

| Metric | Value |
|--------|-------|
| Mean within-subject change | 0.129 |
| Mean between-subject difference | 0.205 |
| Ratio (within/between) | 0.63 |

**Finding:** Within-subject feature change is only 63% of between-subject variation, meaning ResNet features are relatively STABLE over time - they don't capture disease progression well.

---

## Part 3: Feature Separability Analysis

| Comparison | Features with p<0.05 |
|------------|---------------------|
| Stable vs Converter | 123/512 (24%) |
| CN vs Dementia | Much higher |

**Finding:** Features CAN separate CN from Dementia (cross-sectional), but CANNOT reliably separate Stable from Converter (progression).

---

## Part 4: Available Biomarkers in ADNIMERGE

| Feature | Coverage | Purpose |
|---------|----------|---------|
| MMSE | 69.8% | Cognitive function |
| CDRSB | 71.5% | Dementia severity |
| Hippocampus | 53.9% | Atrophy marker |
| Ventricles | 57.7% | Enlargement marker |
| Entorhinal | 51.4% | Early atrophy site |

---

## Part 5: Individual Biomarker Power

### Structural Biomarkers (HONEST - no circularity)

| Biomarker | AUC | Notes |
|-----------|-----|-------|
| **Hippocampus** | **0.725** | Best single predictor |
| Entorhinal | 0.691 | Early atrophy site |
| MidTemp | 0.678 | Temporal lobe |
| Fusiform | 0.670 | Face recognition area |
| WholeBrain | 0.604 | Total volume |
| Ventricles | 0.581 | Enlargement |
| ICV | 0.537 | Head size (not useful) |

### Cognitive Scores (SEMI-CIRCULAR)

| Score | AUC | Notes |
|-------|-----|-------|
| **ADAS13** | **0.767** | Most comprehensive |
| ADAS11 | 0.743 | Shorter version |
| Hippocampus | 0.725 | (for comparison) |
| RAVLT_immediate | 0.720 | Memory test |
| CDRSB | 0.690 | Severity scale |
| RAVLT_learning | 0.677 | Learning ability |
| MMSE | 0.643 | General cognition |
| RAVLT_forgetting | 0.573 | Forgetting rate |

**Key Insight:** Hippocampus volume (0.725) approaches ADAS13 (0.767) in predictive power, and it's a purely biological marker!

---

## Part 6: APOE4 Genetic Risk

| APOE4 Alleles | Conversion Rate | N |
|---------------|-----------------|---|
| 0 alleles | 23.5% | 511 |
| 1 allele | 44.2% | 394 |
| 2 alleles | 49.1% | 110 |

**Finding:** APOE4 carriers have DOUBLE the conversion rate (44-49% vs 23%)!

APOE4 alone: **0.624 AUC**

---

## Part 7: Longitudinal Biomarker Analysis

### Does Temporal Change Help?

| Model | AUC | Notes |
|-------|-----|-------|
| Baseline biomarkers only | 0.736 | Current state |
| Delta (change) only | 0.759 | Atrophy rate |
| **Baseline + Delta** | **0.831** | Combined |

**Improvement from adding longitudinal: +9.5 percentage points!**

---

## Part 8: Best Possible Models

### Model Comparison (5-fold CV)

| Model | AUC |
|-------|-----|
| Logistic Regression | 0.83 |
| Random Forest | 0.82 |
| Gradient Boosting | 0.83 |

All models perform similarly - the features matter more than the algorithm!

### Feature Sets Comparison

| Features | AUC |
|----------|-----|
| ResNet (original) | 0.52 |
| Biomarkers + Delta | 0.83 |
| + Age + APOE4 (honest) | 0.81 |
| + ADAS13 (with cog score) | 0.84 |

---

## Part 9: Demographic Effects

### Conversion Rate by Age

| Age Group | Conversion Rate |
|-----------|-----------------|
| 55-65 | Varies |
| 65-70 | Varies |
| 70-75 | Varies |
| 75-80 | Varies |
| 80-90 | Varies |

### Education Effect

| Education | Conversion Rate |
|-----------|-----------------|
| 0-12 years | 32.4% |
| 12-14 years | 30.4% |
| 14-16 years | 35.0% |
| 16-18 years | 32.1% |
| 18-25 years | 32.3% |

**Finding:** Education level does NOT predict progression - it's roughly 32% across all levels!

---

## Part 10: Follow-up Duration Effect

Longer follow-up = more conversions detected.

1-year follow-up misses many future converters because:
- AD progression takes 2-10 years
- Some MCI patients convert after 2-3 years
- Short studies have censored outcomes

---

## FINAL SUMMARY

### What Went Wrong Originally

1. ‚ùå Used ResNet features (trained on ImageNet, not brains)
2. ‚ùå Mixed all diagnoses (Dementia = Stable is wrong)
3. ‚ùå Generic CNN features can't capture hippocampal atrophy rate

### What Works

1. ‚úÖ Use actual structural biomarkers (hippocampus, ventricles, entorhinal)
2. ‚úÖ Focus on MCI cohort only (clinically meaningful)
3. ‚úÖ Compute longitudinal change (atrophy rate)
4. ‚úÖ Add APOE4 genetic risk factor
5. ‚úÖ Simple logistic regression works - no need for complex models

### Performance Ladder

| Approach | AUC | Improvement vs ResNet |
|----------|-----|----------------------|
| ResNet baseline | 0.52 | - |
| + ResNet delta | 0.52 | +0% |
| Biomarkers baseline | 0.74 | +22% |
| **+ Longitudinal delta** | **0.83** | **+31%** |
| + Age + APOE4 | 0.81 | +29% |
| + ADAS13 | 0.84 | +32% |

---

## Key Takeaways

### 1. Longitudinal Data WORKS
> Hippocampal atrophy RATE is a powerful predictor of MCI‚ÜíDementia conversion. Adding temporal change improves AUC by +9.5 points (0.74 ‚Üí 0.83).

### 2. Right Features > Complex Models
> Simple logistic regression with proper biomarkers (0.83) vastly outperforms complex LSTM with wrong features (0.44).

### 3. Hippocampus is the Best Single Predictor
> Single feature AUC of 0.725 - nearly as good as cognitive tests!

### 4. APOE4 Doubles Risk
> Carriers have 44-49% conversion rate vs 23% for non-carriers.

### 5. ResNet is Wrong for This Task
> ImageNet-pretrained features are scale-invariant and don't capture absolute volume changes.

---

## Recommendations for Future Work

1. **Extract FreeSurfer biomarkers** from MRI instead of ResNet features
2. **Compute annual atrophy rates** for hippocampus and entorhinal cortex
3. **Include APOE4** in all models
4. **Focus on MCI-only cohorts** for progression studies
5. **Use 2+ year follow-up** to capture more conversions
